Cornerstone Capital, Inc. Ocuphire Pharma, Inc. Transaction History

Cornerstone Capital, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$3.01 - $3.85 $49,234 - $62,974	16,357 New	16,357 $61,000
Q2 2022 Aug 15, 2022	BUY	$1.8 - $3.25 $4,500 - $8,125	2,500 Added 22.01%	13,857 $27,000
Q2 2021 Aug 13, 2021	BUY	$4.24 - $6.57 $48,153 - $74,615	11,357 New	11,357 $60,000

2.58M

14.1K

800

Ticker OCUP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,579,800
Market Cap $20.2M
Description
Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...

Get notified when there are updates to the investment portfolio of Cornerstone Capital, Inc., based on Form 13F filings with the SEC.

Stay updated on Cornerstone Capital, Inc. with notifications on news.